Table 4.
Univariate | Multivariable | |||
---|---|---|---|---|
OR (CI%95) | p-Value | aOR (CI%95) | p-Value | |
Traditional anthropometric indices | ||||
BMI ≥ 30 kg/m2 | 1.73 (1.29–2.32) | <0.001 | 1.32 (0.96–1.82) | 0.084 |
WHR > 0.85 in women or 0.94 in men | 1.97 (1.37–2.81) | <0.001 | 1.36 (0.92–2.01) | 0.113 |
WHtR > 0.5 | 5.19 (1.87–14.37) | 0.002 | 2.93 (1.03–8.37) | 0.044 |
Novel anthropometric indices | ||||
ABSI ≥ 0.086 | 1.58 (1.15–2.17) | 0.005 | 1.15 (0.81–1.64) | 0.412 |
AVI ≥ 23.85 | 1.95 (1.43–2.67) | <0.001 | 1.46 (1.04–2.04) | 0.026 |
BAI ≥ 36.23 | 1.44 (1.04–1.98) | 0.026 | 1.13 (0.79–1.60) | 0.491 |
BRI ≥ 6.92 | 2.23 (1.63–3.04) | <0.001 | 1.66 (1.19–2.32) | 0.003 |
CI ≥ 1.39 | 1.88 (1.39–2.55) | <0.001 | 1.28 (0.91–1.81) | 0.150 |
CUN-BAE ≥ 41.07 | 1.43 1.03–1.97 | 0.028 | 1.24 (0.88–1.76) | 0.208 |
WWI ≥ 12.72 | 1.39 (1.01–1.92) | 0043 | 1.29 (0.90–1.83) | 0.155 |
Multivariate analysis was adjusted by age ≥ 65 years, current smokers, hypertension presence, diabetes presence, metabolic syndrome presence, previous CV event, SBP ≥ 140 mmHg, PP ≥ 60 mmHg, TC ≥ 190 mg/dL, LDL ≥ 100 mg/dL, Triglyceride ≥ 200 mg/dL, FPG ≥ 126 mg/dL, antihypertensive, and antidiabetic drugs. Abbreviations: ABSI, a body shape index; AVI, abdominal volume index; aOR, adjusted odds ratio; BAI, body adiposity index; BMI, body mass index; BRI, body roundness index; CI, conicity index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; OR, odds ratio; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; WWI, weight-adjusted waist index.